Atai CEO Rao optimistic about psychedelic therapies despite Lykos setback
FDA's rejection of MDMA therapy for PTSD doesn't dampen hopes for other psychedelic treatments. Read more here.
Spire Wealth Management Acquires New Position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA)
Spire Wealth Management bought a new position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Free Report) in the fourth quarter, ...
Tenaya Therapeutics receives $8M clinical grant from CIRM
Tenaya Therapeutics (TNYA) announced that the California Institute for Regenerative Medicine, CIRM,, a state of California Agency that funds ...
Investing14d
Tenaya Therapeutics announces option repricing to retain staff
In a move to motivate and retain its employees, Tenaya Therapeutics , Inc. (NASDAQ:TNYA), a biotechnology firm specializing in biological products, has announced the repricing of certain stock options ...